STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial
Status:
Completed
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to test if intracerebral haemorrhage (ICH) patients who have contrast
extravasation on computed tomography angiography, the "spot sign", have lower rates of
haematoma growth when treated with tranexamic acid within 4.5 hours of stroke onset, compared
to placebo.